Breaking News

Nitto Denko Avecia Acquires Irvine and Avrio

Significantly expands Avecia's analytical capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Nitto Denko Avecia Inc. (Avecia) has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals, both located in Irvine, CA. Irvine provides analytical development services and Avrio is a cGMP parenteral CMO. Avecia will consolidate both businesses into the newly established company, Nitto Avecia Pharma Services.   The acquisitions, expected to close in October, will expand Avecia’s analytical capabilities and complement its o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters